|
Life Science Software |
|||
| ||||||||||||||||||||||||||||||||
|
Dr. Heinecke is a Professor in the University of Washington Department of Medicine and a member of the Molecular Cell Biology program of the School of Medicine. He holds the Karasinski Chair in Metabolic Research and serves as Director of the Mass Spectrometry Resource for the UW Department of Medicine. Research in the Heinecke laboratory focuses on the role of oxidative reactions in the pathogenesis of atherosclerosis and other inflammatory diseases. "Dr. Heinecke is both a practicing medical doctor and a pioneer in diagnostic proteomics," said Insilicos Chief Scientist Dr. Bryan Prazen. "Heinecke's advice and insight will be of critical importance as Insilicos moves closer to the clinic." "Dr. Heinecke's expertise supports Insilicos' ambition to revolutionize the diagnosis of cardiovascular disease," said Insilicos President Erik Nilsson. "Insilicos' outstanding advisory board shows our connection to cutting-edge research. Heinecke's appointment reflects our growing strength in clinical applications." Insilicos' Scientific Advisory Board comprises: More information on Insilicos' Advisory Board can be found at www.insilicos.com/about.html For more information, visit the Insilicos web site www.insilicos.com or contact Insilicos at info@insilicos.com. 'Insilicos' and 'Life Science Software' are trademarks of Insilicos LLC. |
|||||||||||||||||||||||||||||||||||||||||
| copyright © 2002-2009, Insilicos LLC | ||||||||||||||||||||||||||||||||||||||||||